Immunaeon offers immune cell storage services that preserve healthy immune cells at their peak functionality, preparing individuals for potential future health challenges. This service addresses the decline in immune system strength due to aging, enabling proactive health management against diseases such as infections and cancer.
Funding
$850K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
As individuals age, their immune system's strength naturally declines, increasing vulnerability to infections, cancer, and other diseases. This decline can be further accelerated by lifestyle factors and environmental exposures, leaving individuals less equipped to fight off health challenges.
Solution
Immunaeon provides immune cell storage services, allowing individuals to preserve their healthy immune cells at their peak functionality. By collecting and cryopreserving immune cells, Immunaeon enables proactive health management, ensuring that a younger, more robust immune cell population is available for potential future use. This service aims to mitigate the impact of age-related immune decline and provide a readily accessible source of healthy immune cells to combat disease. The stored cells can potentially be used in future immunotherapies or other treatments to bolster the body's natural defenses.
Target Audience
Immunaeon's primary customers are individuals interested in proactive health management and long-term health security, particularly those concerned about age-related immune decline or with a family history of immune-related diseases.
Features
- Collection and processing of immune cells using advanced cell separation techniques.
- Cryopreservation of immune cells in a state-of-the-art biobank facility.
- Long-term storage of immune cells under optimal conditions to maintain viability and functionality.
- Comprehensive cell characterization and quality control testing to ensure cell integrity.
- Potential future access to stored immune cells for therapeutic applications, subject to medical evaluation and feasibility.